26 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Medications: ... Agent, Initiation Dose ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... #Management #Pain ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Pharmacology # ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Pharmacology # ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... #Pharmacology # ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
administration and missed doses ... #pharmacology #overview ... #review #dosing ... #medications #comparison ... #drugs #table
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
e.g. at lower doses ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... insulin by ~20% • Never ... insulin requirements are ... #pharmacology # ... comparison #table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... : 15 g (4 level ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison